1
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Janet E Hasak, April 14, 1998: US05739277 (217 worldwide citation)

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


2
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Walter H Dreger, February 9, 1999: US05869046 (195 worldwide citation)

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


3
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Wendy Flehr Hohabch Test Albritton & Herbert Lee, September 19, 2000: US06121022 (187 worldwide citation)

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


4
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Merchant & Gould P C, February 14, 2006: US06998253 (15 worldwide citation)

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


5
Presta Leonard G, Snedecor Bradley R: Polypeptides modifies a demi-vie accrue, Altered polypeptides with increased half-life. Genentech, Genentech, Dennison Associates, August 31, 2010: CA2217871

Polypeptides that are cleared from the kidney and do not contain in their original form an Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


6
L G Presta, B R Snedecor: Altered polypeptides with increased half-life. Genentech, xu xun, July 1, 1998: CN96194347

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


7
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Merchant & Gould PC, February 8, 2007: US20070031922-A1

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


8
Leonard G Presta, Bradley R Snedecor: Altered polypeptides with increased half-life. Genentech, Morrison & Foerster, July 10, 2008: US20080166759-A1

Polypeptides that are cleared from the kidney and do not contain in their original form a Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


9
Presta Leonard G, Snedecor Bradley R: Altered polypeptides with increased half-life. Genentech, LEE Wendy M, October 17, 1996: WO/1996/032478

Polypeptides that are cleared from the kidney and do not contain in their original form an Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.


10
Presta Leonard G, Snedecor Bradley R: Altered polypeptides with increased half-life. Genentech, February 4, 1998: EP0821732-A1

Polypeptides that are cleared from the kidney and do not contain in their original form an Fc region of an IgG are altered so as to comprise a salvage receptor binding epitope of an Fc region of an IgG and thereby have increased circulatory half-life.